DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
1-Year Return
22.52%
This Quarter Return
-12.56%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$212M
AUM Growth
-$64.6M
(-23%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
72.97%
Holding
103
New
14
Increased
10
Reduced
14
Closed
19
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$1.74M |
| 2 |
Myriad Genetics
MYGN
|
$1.42M |
| 3 |
Cogent Biosciences
COGT
|
$1.28M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$1.27M |
| 5 |
Bristol-Myers Squibb
BMY
|
$1.16M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$4.53M |
| 2 |
Calumet Specialty Products
CLMT
|
$4.49M |
| 3 |
Invesco AAA CLO Floating Rate Note ETF
ICLO
|
$3.34M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
$1.96M |
| 5 |
Viking Therapeutics
VKTX
|
$1.57M |
Sector Composition
| 1 | Healthcare | 33.25% |
| 2 | Materials | 20.41% |
| 3 | Financials | 19.12% |
| 4 | Communication Services | 8.29% |
| 5 | Industrials | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Leap Therapeutics
LPTX
$11.8M
| – | – |
-23,626
| Closed | -$67.9K |
|